Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma
NCT06256185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1267
Last updated 2024-02-13
Summary
Existing models do poorly when it comes to quantifying the risk of Lymph node metastases (LNM). This study generated elastic net regression (ELR), random forest (RF), extreme gradient boosting (XGB), and a combined (ensemble) model of these for LNM in patients with T1 esophageal squamous cell carcinoma.
Conditions
- Lymph Node Metastasis
Interventions
- PROCEDURE
-
esophagectomy
Resection of esophageal tumor and lymph node dissection
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-15
- Primary Completion
- 2019-12-15
- Completion
- 2023-07-15
Countries
- China
Study Locations
More Related Trials
-
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma(RENMIN-237)
NCT05980403 ·Status: RECRUITING
-
Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
NCT06165094 ·Status: COMPLETED
-
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
NCT06241066 ·Status: COMPLETED
-
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
NCT05570487 ·Status: UNKNOWN
-
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
NCT07088354 ·Status: RECRUITING
-
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895 ·Status: RECRUITING
-
Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features
NCT07181850 ·Status: COMPLETED
-
Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT01745107 ·Status: UNKNOWN ·Phase: PHASE3
-
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT05420480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study
NCT07251114 ·Status: RECRUITING ·Phase: NA
-
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123 ·Status: COMPLETED ·Phase: PHASE3
-
Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology
NCT07203690 ·Status: NOT_YET_RECRUITING
-
Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma
NCT06412419 ·Status: NOT_YET_RECRUITING
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy
NCT06169930 ·Status: COMPLETED
-
Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer
NCT03029793 ·Status: UNKNOWN
-
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
NCT05617352 ·Status: COMPLETED
-
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC
NCT04759235 ·Status: UNKNOWN
-
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
NCT00921739 ·Status: COMPLETED ·Phase: PHASE1
-
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
NCT02448979 ·Status: UNKNOWN ·Phase: PHASE3
-
China Early Esophageal Cancer Cohort
NCT06515964 ·Status: RECRUITING
-
Follow-up Strategy for Esophageal Cancer Patients
NCT06045715 ·Status: UNKNOWN
-
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
NCT05628610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
NCT00012168 ·Status: COMPLETED ·Phase: NA
-
Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT06596954 ·Status: RECRUITING ·Phase: NA